Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-46.96	15.25	28.76
Graham Fair Price	41.42	12.13	8.58
PEG	-64.11	0.08	-0.23
Price/Book	-8.41	0.18	0.20
Price/Cash Flow	178.03	21.69	-7.80
Prices/Earnings	-54.20	7.86	17.16
Price/Sales	-54.20	0.47	1.02
Price/FCF	178.03	21.69	-7.80
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	4.48	0.12	0.11
Operating Margin	-23.19	0.04	0.05
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	-18.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.05	0.21	-75.84
Dividends QOQ	2.50	< 0.005	-100.00
EBIT QOQ	-0.09	0.54	516.15
EPS QOQ	-0.75	0.96	27.62
FCF QOQ	-1.50	1.33	-11.11
Revenue QOQ	-0.48	1.00	108.47
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	165.39	83.17	-49.71
Days Sales Outstanding (DSO)	65.58	35.34	-46.12
Inventory Turnover	0.54	1.08	98.85
Debt/Capitalization	0.32	0.31	-3.51
Quick Ratio	0.71	0.89	24.76
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	33.72	33.72	< 0.005
Cash	8.79	11.77	33.92
Capex	-0.11	-0.23	-101.68
Free Cash Flow	-0.85	0.28	-67.06
Revenue	6.50	13.00	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.58	1.58	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.00	7.84	-47.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating